|Articles|August 1, 2018
- Pharmaceutical Executive-08-01-2018
- Volume 38
- Issue 8
Pharmaceutical Executive, August 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive August 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 8 years ago
Emerging Biotech: Innovation, Location, and Inspirationabout 8 years ago
Cross-Border Funding in the Life Sciencesabout 8 years ago
Face It. You’re Not a Biotech Anymoreabout 8 years ago
The Pulse of Biopharma M&Aabout 8 years ago
The Big Apple’s Fresh Start in Biotechabout 8 years ago
‘Emerging’ Product Launch Strategiesabout 8 years ago
Biotech Investment: Reigning in Spainabout 8 years ago
Traditional Scientific Search is Brokenabout 8 years ago
Tough Fight Looms in Preserving R&D Incentivesabout 8 years ago
From Science to SuccessAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
FDA Approves Lisraya for Adults with Dermatomyositis, Bixlenvo for Virologically Suppressed Adults with HIV, Mounjaro to Reduce MACE in Adults with Type 2 Diabetes
3
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
4
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
5